Levitra Talks
SUBSCRIPTION
  LInks  
Bookmark this Site
 
 Year 2007
   » August 2007
   » July 2007
   » June 2007
   » May 2007
   » Apr 2007
   » Mar 2007
   » Feb 2007
   » Jan 2007
 Year 2006
   » Dec 2006
   » Nov 2006
   » Oct 2006
   » Sept 2006
   » Aug 2006
   » July 2006
   » June 2006
   » May 2006
   » April 2006
   » Mar 2006
   » Feb 2006
   » Jan 2006
 Year 2005
   » Dec 2005
   » Nov 2005
   » Oct 2005
   » Sep 2005
   » Aug 2005
   » July 2005
   » June 2005
   » May 2005
   » Mar 2005
   » Feb 2005
   » Jan 2005
 Year 2004
 Year 2003
 Levitra information
   
Get To Know ED
What is Levitra?
  » FDA Approval
» History & Present Status
Who is Behind Levitra?
Levitra Expectations
Tips for First Timers
Patient Leaflet
Levitra Side Effects
  » Levitra Safety
Levitra Pharmacology
  » Levitra Clinical Data
PDE5 Inhibitors
ED Quiz
Levitra News
   
 
 

  News Home » January 2007

Bedroom Help for Diabetic Men
Saturday, 26 January 2007

(Ivanhoe Newswire) -- Diabetic men who are unable to perform in the bedroom can get help from drugs like Viagra and Levitra. Erectile dysfunction drugs are safe and effective for diabetes patients, new research reveals.

Men with diabetes are three-times more likely than healthy men to suffer from erectile dysfunction, according to the National Institute of Diabetes and Digestive and Kidney Diseases. But diabetic patients have to be careful about the drugs they take -- side effects can complicate chronic health problems. Health complications, like heart disease and high blood pressure, are linked to diabetes.

Researchers with The Cochrane Collaboration performed a meta-analysis of eight studies on several types of phosphodiesterase type 5 (PDE-5) inhibitors, a drug category that includes Viagra, Levitra and Cialis. The studies involved a total of 1,759 diabetic men, 80 percent having type-2 diabetes. Researchers found men who took PDE-5 inhibitors experienced 26.7 percent more "successful intercourse attempts" compared to placebo groups.

Some patients experienced side effects such as headache, upper respiratory tract complaints and flu-like symptoms. However, researchers report PDE-5 inhibitors do not appear to put diabetes patients at-risk for serious short-term complications.

Researchers say more research is needed to determine long-term risks for diabetic men taking PDE-5 inhibitors. Most of the studies in the meta-analysis lasted just 12 weeks.

 



Source::
http://www.drkoop.com/newsdetail/



Disclaimer
| Levitra | Levitra Articles
Levitra ® is a registered trademark of Bayer AG and GlaxoSmithKline PLC.
Copyright © 2005 levitratalks.com, All rights reserved.